Drug makers are finding themselves in an inevitable position. Since the start of the coronavirus crisis, share prices have soared and public criticism has grown muted. However an elaborate cover-up is underway to hide a sordid past.
A well-renowned infectious disease expert from the University of Minnesota has warned that the novel Coronavirus disease can potentially spread to 70% of the population without an effective vaccine before it reaches global herd immunity.
Does smoking better adapt the human lungs to fight Covid-19? Not quite. But nicotine is under the microscope as a possible preventive measure against the need for hospitalization. Moreover, will nicotine in tea instead of tobacco have the same impact that prevents Covid-19 causing an immune overreaction?